-
Sector Analysis
![]()
Chronic Myeloid Leukemia (CML): Global Drug Forecast and Market Analysis to 2030
The 8MM CML market was valued at $4.25 billion in 2020, and expects sales to peak in 2023, before falling at a CAGR of more than -3% during the period 2020-2030. The market growth will be driven by the launch or expansion of four agents, an increase in prevalent cases, and increased adoption of branded second and third-generation tyrosine kinase inhibitors (TKIs). Growth will be substantially inhibited by the patent expiries of all but one of the currently marketed TKIs...
-
Sector Analysis
![]()
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – South Korea
The South Korean medical device market was valued at $9.95 billion in 2020 and is expected to grow at a CAGR of over 4% during the period 2021-2027. South Korea is the world's 10th largest pharmaceutical market and considers the pharmaceutical industry a potential growth engine for the country's future economic growth. South Korea's pharmaceutical manufacturing industry is accelerating its transformation due to increased support from government policies such as the five-year comprehensive plan and the steadily rising coronavirus-related deals....
-
Sector Analysis
![]()
Plaque Psoriasis: Global Drug Forecast and Market Analysis to 2030
The global plaque psoriasis (PsO) market was valued at $14.2 billion in 2020 and is projected to record a growth of more than 6% during the forecast period 2021-2030. The major growth drivers of the global PsO market are new product launches, a steady increase in total diagnosed prevalence across the 7MM, and increased treatment options for mild and moderate patients. The major barriers to growth in the PsO market during the forecast period include loss of patent expiry and...
-
Sector Analysis
![]()
Hypoglycemia Drug Market Size, Company Share, Trends Analysis and Forecast 2021-2030
The hypoglycemia drug sales have been valued to $423.5 million across the 7MM in 2020 growing at a CAGR of more than 4%. The US has contributed more than 90% of the sales that is primarily due to the significantly higher prices of glucagons in the US, a relatively high diagnosed prevalence of type 1 diabetes (T1D) and high incidence rate of post-bariatric hypoglycemia (PBH). The next largest individual markets are Italy and Germany. Therefore, altogether the 5EU countries make...
-
Product Insights
![]()
Tissue Adhesives Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021
The tissue adhesives pipeline product market report provides comprehensive information about the tissue adhesives pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. Tissue adhesives consist of polymers that form a thin protective film and create a strong adherent bond to hold the edges of wounds on the skin. This allows for proper healing of the wound under the film and protects the wound from...
-
Sector Analysis
![]()
Sepsis Therapeutics Market Size, Share & Trends Analysis and Forecast 2021 – 2030
The global sepsis market has been valued at $3.48 billion in 2020 and is expected to grow at a CAGR of more than 7.5% across the seven major pharmaceutical markets (7MM) the US, 5EU (France, Germany, Italy, Spain, and the UK), and Japan during the forecast period. As of 2020, the market has been dominated by antibiotics and supportive therapies for the treatment of sepsis, most of which are available as generic versions. Due to its high diagnosed incidence rate...
-
Analyst Opinions
![]()
Utilities 2.0: how digitization and decentralization are unlocking new possibilities in power
Emerging technologies are breaking paradigms in the power sector with improved asset management, smart processes, optimal power generation, transmission, and distribution as well as enriched customer experiences. They are enabling power companies to sustainably generate electricity while curbing expenses to make profits. The manufacture of industrial assets has been in play for a while now in the power sector and recently emerging technologies such as 3D printing, IoT, and AI are enabling the development of highly resilient parts, intelligent boilers...
-
Sector Analysis
![]()
Migraine Drug Market Size, Share & Trends Analysis and Forecast by Strategic Competitor Assessment, Market Characterization, Unmet Needs, Clinical Trial Mapping and Implications 2020 – 2030
The global sales for migraine drugs have been valued at $4.6 billion in 2020 with a CAGR of more than 9%. The US has dominated the migraine market, contributing to more than 80% of the sales in the seven major pharmaceutical markets (7MM) covered - the US, 5EU (France, Germany, Italy, Spain, and the UK), and Japan. A high market share in US is attributed to the large migraine prevalent population, the costliness of branded drugs, and the number of...
-
Thematic Analysis
![]()
Edtech – Thematic Research
According to GlobalData forecasts, the Edtech market grew by more than 10% in 2019. The following year, COVID-19 kickstarted faster growth. In 2020, Edtech market revenue was worth $149.2 billion. The global Edtech revenues are expected to grow at a CAGR of more than 10% during 2019-2030. Edtech fueled by the impact of COVID-19 has grown into a global industry with economic and political implications. The growth in Edtech provides a cogent argument that its place in learning is not...
-
Thematic Analysis
![]()
Long-Term Impact of COVID-19 on Apparel Industry – Thematic Research
The global apparel market sales were valued at $1,663 billion in 2020 in post COVID-19 period. The market is projected (post-COVID-19) to grow at a CAGR of more than 1% during the forecast period. Retail stores and suppliers have faced significant challenges amid COVID-19. Order cancellations and a limited workforce have heightened issues related to cash flow and logistics throughout their supply chain. Also, the travel restrictions adopted by almost all countries across the globe led to a massive fall...
-
Sector Analysis
![]()
Top 50 Global Clothing, Footwear and Accessories Specialist Retailers Sales, Market Share, Positioning and Key Performance Indicators (KPIs)
This brief lists the Top 50 department store retailers by sales in 2020, which includes sales tax, per calendar year, making the data and market shares comparable.
-
Sector Analysis
![]()
Neuroendocrine Tumors (NETs) – Global Drug Forecast and Market Analysis to 2030
The global neuroendocrine tumors drug market was valued at $3.11 billion in 2020 and is projected to grow at a CAGR of more than 0.5% during the forecast period 2021-2030. The introduction of five new pipeline agents and label expansions or entry into new markets for currently approved agents are key drivers of this market growth. However, the market will largely stagnate during the forecast period due to patent expiries impacting most of the standard of care. The US was...
-
Sector Analysis
![]()
Qatar Construction 2021 – New Trends, Opportunities, and Challenges for Construction as Qatar looks beyond 2022 – MEED Insights
The Qatar construction market has proved itself to be highly adaptable and resilient in the face of considerable financial and logistical challenges over the past five years from the COVID-19 pandemic, lower energy prices, and the GCC diplomatic dispute, each of which has affected national finances and industry supply chains. Unlike most other construction markets in the Middle East and North Africa (MENA) region, Qatar performed consistently in 2020, with about $10.5 billion of construction and transport project contract awards.
-
Sector Analysis
![]()
HER2+ Breast Cancer – Global Drug Forecast and Market Analysis to 2030
GlobalData valued the 8MM HER-2 + breast cancer market at $10.4 billion in 2020 and expects the market to increase at a low compound annual growth rate (CAGR) of more than 1%. This growth will be driven by the anticipated launches of five pipeline agents, the expansion of several currently approved agents into earlier lines of therapy, and a collective increase in the diagnosed incident population across the 8MM. Growth will be substantially inhibited by generic and biosimilar erosion following...
-
Sector Analysis
![]()
Womenswear in Canada – Sector Overview, Brand Shares, Market Size and Forecast to 2025
Womenswear in Canada - Sector Overview, Brand Shares, Market Size and Forecast to 2025 provides both the historic and forecast market data of total apparel sales, and the womenswear market in Canada. It illustrates the data with charts, graphs and tables summarizing the value and volume trends, with category details in womenswear. The forecasts include the impact of COVID-19 on growth. The report also reveals major brand’s share in apparel & womenswear with their price and market positioning in 2020....
-
Sector Analysis
![]()
Menswear in Canada – Sector Overview, Brand Shares, Market Size and Forecast to 2025
Menswear in Canada - Sector Overview, Brand Shares, Market Size and Forecast to 2025 provides both the historic and forecast market data of total apparel sales, and the menswear market in Canada. It illustrates the data with charts, graphs and tables summarizing the value and volume trends, with category details in menswear. The forecasts include the impact of COVID-19 on growth. The report also reveals major brand’s share in apparel & menswear with their price and market positioning in 2020....
-
Sector Analysis
![]()
Womenswear in the United States of America (USA) – Sector Overview, Brand Shares, Market Size and Forecast to 2025
Womenswear in the United States of America (USA) - Sector Overview, Brand Shares, Market Size and Forecast to 2025 provides both the historic and forecast market data of total apparel sales, and the womenswear market in United States. It illustrates the data with charts, graphs and tables summarizing the value and volume trends, with category details in womenswear. The forecasts include the impact of COVID-19 on growth. The report also reveals major brand’s share in apparel & womenswear with their...
-
Sector Analysis
![]()
Cystic Fibrosis – Global Drug Forecast and Market Analysis to 2030
The global (7MM) sales for the cystic fibrosis (CF) have been valued at $8.2 billion in 2020. The market is expected to grow at a CAGR of more than 4% during 2021-2025. Over the past decade, there have been significant changes in the CF market due to the development of CFTR modulator therapies that target the underlying cause of CF. Most of the sales has come from the US, which represents more than 75% of the market by 2030. The...
-
Sector Analysis
![]()
Respiratory Syncytial Virus Prophylaxis – Global Drug Forecast and Market Analysis to 2030
Respiratory syncytial virus (RSV) is a common respiratory infection that most children will be infected with by the time they are two years old. RSV infection generally causes mild flu-like symptoms, which can include a runny nose, lowered appetite, fever, coughing, and/or sneezing. Irritability and difficulty breathing may be the only symptoms shown by very young infants with RSV. RSV is a viral infection that is transmitted through contact with droplets in the air or on surfaces like doorknobs, tabletops,...
-
Sector Analysis
![]()
Global Hematological Cancer (Blood Cancer) Therapy Market to 2027 – Comprehensive Overview of Marketed and Pipeline Products, Opportunities, Challenges, Market Size and Key Players
The market value for therapies used in the treatment of hematological cancers has increased substantially in the past 10 years. The total sales for marketed therapeutics for hematological cancers were valued at $58 billion in 2020. The total sales include the sales of branded and biosimilar marketed agents, but not generics. The hematological cancer therapy market is diverse and highly genericized. There are 2,406 marketed molecules for the treatment of hematological cancers available globally. The majority of these are generic...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.